DE602005024373D1 - Verfahren zur chromatographischen reinigung - Google Patents

Verfahren zur chromatographischen reinigung

Info

Publication number
DE602005024373D1
DE602005024373D1 DE602005024373T DE602005024373T DE602005024373D1 DE 602005024373 D1 DE602005024373 D1 DE 602005024373D1 DE 602005024373 T DE602005024373 T DE 602005024373T DE 602005024373 T DE602005024373 T DE 602005024373T DE 602005024373 D1 DE602005024373 D1 DE 602005024373D1
Authority
DE
Germany
Prior art keywords
chromatography matrix
target compound
ionic polyether
chromatographic
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024373T
Other languages
English (en)
Inventor
Alstine James Van
Hamid Houshmand
Anders Ljungloef
Per-Mikael Aberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
GE Healthcare Bio Sciences AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences AB filed Critical GE Healthcare Bio Sciences AB
Publication of DE602005024373D1 publication Critical patent/DE602005024373D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G01N30/46—Flow patterns using more than one column
    • G01N30/461—Flow patterns using more than one column with serial coupling of separation columns

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Peptides Or Proteins (AREA)
  • Polyethers (AREA)
DE602005024373T 2004-04-02 2005-03-31 Verfahren zur chromatographischen reinigung Active DE602005024373D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400886A SE0400886D0 (sv) 2004-04-02 2004-04-02 Process of purification
PCT/SE2005/000467 WO2005094960A1 (en) 2004-04-02 2005-03-31 A method for chromatographic purification

Publications (1)

Publication Number Publication Date
DE602005024373D1 true DE602005024373D1 (de) 2010-12-09

Family

ID=32173667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024373T Active DE602005024373D1 (de) 2004-04-02 2005-03-31 Verfahren zur chromatographischen reinigung

Country Status (9)

Country Link
US (1) US20070213513A1 (de)
EP (1) EP1729867B1 (de)
JP (1) JP4831697B2 (de)
AT (1) ATE485880T1 (de)
AU (1) AU2005228834A1 (de)
CA (1) CA2560012A1 (de)
DE (1) DE602005024373D1 (de)
SE (1) SE0400886D0 (de)
WO (1) WO2005094960A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008033517A2 (en) 2006-09-13 2008-03-20 Abbott Laboratories Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
US8268915B2 (en) * 2007-06-19 2012-09-18 Ge Healthcare Bio-Sciences Ab Polymer two phase system and use thereof
KR20100103595A (ko) * 2008-01-18 2010-09-27 에프. 호프만-라 로슈 아게 비-글라이코실화된 단백질의 정제
JP5596560B2 (ja) * 2008-02-05 2014-09-24 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 分離媒体の製造方法
FR2930780B1 (fr) * 2008-04-30 2010-08-20 Moet & Chandon Procede de degorgement de vins mousseux
AU2009256308A1 (en) * 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
EP2921501A1 (de) * 2008-10-20 2015-09-23 Abbvie Inc. Isolation und Aufreinigung von Antikörpern mit Protein-A-Affinitätschromatografie
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
SI3318571T1 (sl) 2011-03-16 2021-08-31 F. Hoffmann-La Roche Ag Ionska izmenjevalna kromatografija z izboljšano selektivnostjo za ločevanje polipeptidnih monomerov, agregatov in fragmentov s spremembo mobilne faze
CN107915769A (zh) 2011-03-29 2018-04-17 葛兰素史密斯克莱有限责任公司 用于蛋白纯化的缓冲液体系
CN103717284B (zh) * 2011-06-08 2016-02-24 新加坡科技研究局 通过约束共水合色谱纯化生物制品
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2015041218A1 (ja) * 2013-09-17 2015-03-26 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体（Ｎｏｖｅｌ Ａｎｔｉｂｏｄｙ Ｐｕｒｉｆｉｃａｔｉｏｎ Ｍｅｔｈｏｄ ａｎｄ Ａｎｔｉｂｏｄｙ ｏｂｔａｉｎｅｄ ｔｈｅｒｅｆｒｏｍ）、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体（Ｎｏｖｅｌ Ａｎｔｉｂｏｄｙ Ｐｕｒｉｆｉｃａｔｉｏｎ ｍｅｔｈｏｄ ｕｓｉｎｇ Ｃａｔｉｏｎ Ｅｘｃｈａｎｇｅｒ ａｎｄ Ａｎｔｉｂｏｄｙ ｏｂｔａｉｎｅｄ ｔｈｅｒｅｆｒｏｍ）
CN109641050A (zh) 2016-08-16 2019-04-16 里珍纳龙药品有限公司 用于对混合物中的个体抗体进行量化的方法
CN109923411B (zh) 2016-10-25 2022-05-31 里珍纳龙药品有限公司 用于色谱数据分析的方法和系统
CN108152104B (zh) * 2017-12-25 2020-08-11 上海微谱化工技术服务有限公司 超支化水性聚氨酯中二氧化硅填料的分离及定量方法
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
US11420916B2 (en) * 2018-06-08 2022-08-23 Board Of Regents, The University Of Texas System Systems and methods for separation of olefins from mixtures that contain reducing agents
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
WO2021064066A1 (en) * 2019-10-04 2021-04-08 Merck Patent Gmbh Elution of monoclonal antibodies in protein a affinity chromatography

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
DE3483620D1 (de) * 1983-03-11 1991-01-03 Fujirebio Kk Verfahren zur bestimmung von liganden.
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
US5151358A (en) * 1989-06-13 1992-09-29 Genencor International, Inc. Processes for the recovery of naturally produced chymosin
DE4321904B4 (de) * 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
WO1998017312A1 (fr) * 1996-10-22 1998-04-30 Chugai Seiyaku Kabushiki Kaisha Remede contre les troubles septiques et comprenant un anticorps anti-il-8 en qualite d'ingredient actif
AUPR110100A0 (en) * 2000-10-30 2000-11-23 Life Therapeutics Limited Improved separation of macromolecules
US7514078B2 (en) * 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
US7998705B2 (en) * 2002-08-06 2011-08-16 FUJIFILM Diosynth Biotechnologies U.S.A., Inc Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins

Also Published As

Publication number Publication date
US20070213513A1 (en) 2007-09-13
EP1729867A1 (de) 2006-12-13
CA2560012A1 (en) 2005-10-13
JP2007530971A (ja) 2007-11-01
WO2005094960A1 (en) 2005-10-13
AU2005228834A1 (en) 2005-10-13
EP1729867B1 (de) 2010-10-27
ATE485880T1 (de) 2010-11-15
JP4831697B2 (ja) 2011-12-07
SE0400886D0 (sv) 2004-04-02

Similar Documents

Publication Publication Date Title
DE602005024373D1 (de) Verfahren zur chromatographischen reinigung
Schroeder et al. A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry
Gilar et al. Orthogonality of separation in two-dimensional liquid chromatography
Meert et al. Characterization of antibody charge heterogeneity resolved by preparative immobilized pH gradients
DK1725581T3 (da) Ny assay til adskillelse og kvantificering af hæmagglutinin-antigener
NO20072863L (no) Fremgangsmate til a rense FSH
ATE428728T1 (de) Verfahren zur reinigung von erythropoietin
BRPI0515970A (pt) materiais de ligação de proteìna prìon e métodos de uso
JP2007530971A5 (de)
ATE337058T1 (de) Kolonne und mit dieser durchgeführtes chromatographisches verfahren
WO2005100394A3 (en) PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF
DK1841863T3 (da) Fremgangsmåde til rensning af faktor VII
BRPI0513526A (pt) componentes de aparelho e métodos de utilizar componentes de aparelho para detectar a presença de um analisado
WO2003076949A3 (en) Tagging and recovery of elements associated with target molecules
WO2009139601A3 (en) Method and affinity column for purifying proteins
WO2009003952A3 (en) Column and method for preparing a biological sample for protein profiling
WO2007036564A3 (de) Verfahren und formulierung zur extraktion von nukleinsäuren aus beliebigen komplexen ausgangsmaterialien
Kleemann et al. Characterization of IgG1 immunoglobulins and peptide− Fc fusion proteins by limited proteolysis in conjunction with LC− MS
WO2008017951A3 (en) Making a call by a prepaid subscriber roaming in a visited non-camel network
BRPI0606168A2 (pt) separação de isÈmeros de fulvestrant
GB2427374A (en) Compositions and methods for separating enantiomers
WO2010028094A8 (en) Evaluating heparin preparations for pharmaceutical use
DK1951395T3 (da) Fremgangsmåde til kvantitativ bestemmelse af poloxamerer
ATE473290T1 (de) Proteomweite quantifizierung kleiner an zelluläre zielproteine gebundener moleküle
DE602004013040D1 (de) Aufreinigung von immunglobulinen